National University Cancer Institute Singapore, National University Health System, 5 Lower Kent Ridge Road, Singapore 119074, Singapore.
Int J Infect Dis. 2010 Jun;14(6):e518-21. doi: 10.1016/j.ijid.2009.06.009. Epub 2009 Aug 21.
Fever occurs frequently in cancer patients, and neoplastic fever is a well-described paraneoplastic phenomenon in patients with lymphoma, acute leukemias, and renal cell carcinoma. It is also more commonly encountered in metastatic disease. Treatment options include disease-specific therapy, non-steroidal anti-inflammatory drugs (NSAIDs), and steroids. Lung cancer is one of the most common cancers, yet fever as a manifestation of this malignancy has not been emphasized. In this report, we describe an unusual case of non-metastatic non-small cell lung cancer (NSCLC) presenting with neoplastic fever at both diagnosis and relapse, responding on each occasion to disease-specific treatment, and provide a review of the management of neoplastic fever.
发热在癌症患者中很常见,肿瘤性发热是淋巴瘤、急性白血病和肾细胞癌患者中一种描述明确的副瘤现象。它在转移性疾病中也更为常见。治疗选择包括针对疾病的治疗、非甾体抗炎药(NSAIDs)和类固醇。肺癌是最常见的癌症之一,但发热作为这种恶性肿瘤的表现尚未得到重视。在本报告中,我们描述了一例非转移性非小细胞肺癌(NSCLC)的不寻常病例,该病例在诊断和复发时均表现为肿瘤性发热,每次均对针对疾病的治疗有反应,并对肿瘤性发热的治疗进行了回顾。